UnitedHealth stock is trading -27.21% below its average target price of $552.84 after dropping -1.7% during today's morning session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $490.0 to $677.0 per share.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.3%. The stock's short ratio is 2.04. The company's insiders own 0.24% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 90.7%. In conclusion, we believe there is positive market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 9% | 85,146,242 | $34,266,253,838 |
| 2024-12-31 | Blackrock Inc. | 8% | 72,014,896 | $28,981,674,922 |
| 2024-12-31 | State Street Corporation | 5% | 45,592,903 | $18,348,407,994 |
| 2024-12-31 | FMR, LLC | 3% | 30,120,629 | $12,121,746,008 |
| 2024-12-31 | JPMORGAN CHASE & CO | 3% | 24,432,835 | $9,832,750,177 |
| 2024-12-31 | Wellington Management Group, LLP | 3% | 23,361,101 | $9,401,441,543 |
| 2024-12-31 | Capital World Investors | 2% | 21,515,729 | $8,658,790,031 |
| 2024-12-31 | Price (T.Rowe) Associates Inc | 2% | 21,401,754 | $8,612,921,932 |
| 2024-12-31 | Morgan Stanley | 2% | 21,396,198 | $8,610,685,975 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 19,956,219 | $8,031,180,823 |
